Coherus Oncology (CHRS) Times Interest Earned: 2013-2025
Historic Times Interest Earned for Coherus Oncology (CHRS) over the last 11 years, with Sep 2025 value amounting to -$19.07.
- Coherus Oncology's Times Interest Earned fell 15.04% to -$19.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.69, marking a year-over-year increase of 65.87%. This contributed to the annual value of -$4.11 for FY2024, which is 17.96% up from last year.
- Coherus Oncology's Times Interest Earned amounted to -$19.07 in Q3 2025, which was up 4.55% from -$19.98 recorded in Q2 2025.
- Coherus Oncology's 5-year Times Interest Earned high stood at $2.32 for Q4 2024, and its period low was -$29.63 during Q1 2021.
- For the 3-year period, Coherus Oncology's Times Interest Earned averaged around -$11.45, with its median value being -$9.76 (2024).
- Data for Coherus Oncology's Times Interest Earned shows a peak YoY increase of 135.81% (in 2024) and a maximum YoY decrease of 431.73% (in 2024) over the last 5 years.
- Quarterly analysis of 5 years shows Coherus Oncology's Times Interest Earned stood at -$6.83 in 2021, then rose by 19.63% to -$5.49 in 2022, then dropped by 18.26% to -$6.49 in 2023, then soared by 135.81% to $2.32 in 2024, then dropped by 15.04% to -$19.07 in 2025.
- Its Times Interest Earned was -$19.07 in Q3 2025, compared to -$19.98 in Q2 2025 and -$21.13 in Q1 2025.